Literature DB >> 22541291

Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.

Jamie O Edgin1, Gina M Mason, Goffredina Spanò, Andrea Fernández, Lynn Nadel.   

Abstract

The study of cognitive function in Down syndrome (DS) has advanced rapidly in the past decade. Mouse models have generated data regarding the neurological basis for the specific cognitive profile of DS (i.e., deficits in aspects of hippocampal, prefrontal, and cerebellar function) and have uncovered pharmacological treatments with the potential to affect this phenotype. Given this progress, the field is at a juncture in which we require assessments that may effectively translate the findings acquired in mouse models to humans with DS. In this chapter, we describe the cognitive profile of humans with DS and associated mouse models, discussing the ways in which we may merge these findings so as to more fully understand cognitive strengths and weaknesses in this population. New directions for approaches to cognitive assessment in mice and humans are discussed.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22541291     DOI: 10.1016/B978-0-444-54299-1.00007-8

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  11 in total

1.  Adaptation of the Arizona Cognitive Task Battery for use with the Ts65Dn mouse model (Mus musculus) of Down syndrome.

Authors:  Michael R Hunsaker; Genevieve K Smith; Raymond P Kesner
Journal:  J Comp Psychol       Date:  2017-03-23       Impact factor: 2.231

2.  Sorting receptors at Down's syndrome synapses.

Authors:  Matt W Jones
Journal:  Nat Med       Date:  2013-04       Impact factor: 53.440

3.  The medial temporal memory system in Down syndrome: Translating animal models of hippocampal compromise.

Authors:  Caron A C Clark; Fabian Fernandez; Stella Sakhon; Goffredina Spanò; Jamie O Edgin
Journal:  Hippocampus       Date:  2017-03-27       Impact factor: 3.899

4.  Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Jessica Yu; Jeesun Kim; Larisa V Lysenko; Zheng Zeng; Y Eugene Yu; William C Mobley
Journal:  Neurobiol Dis       Date:  2017-03-22       Impact factor: 5.996

Review 5.  Stem and progenitor cell dysfunction in human trisomies.

Authors:  Binbin Liu; Sarah Filippi; Anindita Roy; Irene Roberts
Journal:  EMBO Rep       Date:  2014-12-17       Impact factor: 8.807

6.  Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.

Authors:  Larisa V Lysenko; Jeesun Kim; Cassandra Henry; Anna Tyrtyshnaia; Rebecca A Kohnz; Francisco Madamba; Gabriel M Simon; Natalia E Kleschevnikova; Daniel K Nomura; R Alan B Ezekowitz; Alexander M Kleschevnikov
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  VNTR-DAT1 and COMTVal158Met Genotypes Modulate Mental Flexibility and Adaptive Behavior Skills in Down Syndrome.

Authors:  Laura Del Hoyo; Laura Xicota; Klaus Langohr; Gonzalo Sánchez-Benavides; Susana de Sola; Aida Cuenca-Royo; Joan Rodriguez; Jose Rodríguez-Morató; Magí Farré; Mara Dierssen; Rafael de la Torre
Journal:  Front Behav Neurosci       Date:  2016-10-17       Impact factor: 3.558

8.  Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.

Authors:  Martina Parrini; Diego Ghezzi; Gabriele Deidda; Lucian Medrihan; Enrico Castroflorio; Micol Alberti; Pietro Baldelli; Laura Cancedda; Andrea Contestabile
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

Review 9.  Building an adaptive brain across development: targets for neurorehabilitation must begin in infancy.

Authors:  Jamie O Edgin; Caron A C Clark; Esha Massand; Annette Karmiloff-Smith
Journal:  Front Behav Neurosci       Date:  2015-09-11       Impact factor: 3.558

10.  Weaker control of the electrical properties of cerebellar granule cells by tonically active GABAA receptors in the Ts65Dn mouse model of Down's syndrome.

Authors:  Marianna Szemes; Rachel L Davies; Claire Lp Garden; Maria M Usowicz
Journal:  Mol Brain       Date:  2013-07-19       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.